newsfilter
← Latest News
Business Wire·

Versantis Appoints Mark Fitzpatrick, Seasoned Biotech Executive, as its New CEO

- Versantis establishes wholly-owned U.S. subsidiary, Versantis, Inc. - - Current CEO, Vincent Forster, to maintain his key role as Chief Scientific Officer - Versantis, a clinical-stage biotechnology company developing novel therapies for orphan